Daxor (DXR) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Daxor (DXR) has outperformed Retractable Technologies (RVP) over the past year, losing 20.0% versus a loss of 28.0%. Over five years, DXR leads with a -7.0% price change compared with -92.8% for RVP. Daxor is the larger company by market cap ($60.8 million vs $19.9 million), about 3.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | RVP |
|---|---|---|
| Share price | $10.41 | $0.6632 |
| Market cap | $60.78M | $19.85M |
| 1-day change | -0.48% | +0.18% |
| YTD return | -29.08% | -14.03% |
| 1-year return | -20.03% | -28.04% |
| 5-year return | -7.02% | -92.76% |
| P/E ratio (TTM) | 9.46 | — |
| EPS (TTM) | $1.10 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.76 | $1.14 |
| 52-week low | $8.56 | $0.60 |
| Distance from 52-week high | -29.47% | -41.82% |
| Analyst consensus | none | — |
| Avg. price target upside | +92.12% | — |
| Average volume | 17.27K | 27.81K |
| Shares outstanding | 5.84M | 29.94M |
| Employees | — | 195 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Daxor is about 3.1 times larger than Retractable Technologies by market value ($60.78M vs $19.85M).
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Health Care · Medical/Dental Instruments · 195 employees
DXR vs RVP FAQ
Which is bigger, Daxor or Retractable Technologies?
Daxor (DXR) is larger, with a market capitalization of $60.78M compared with $19.85M for Retractable Technologies (RVP).
Which stock has performed better over the past year, DXR or RVP?
DXR returned -20.03% over the past 12 months, compared with -28.04% for RVP (price return, excluding dividends). Past performance does not predict future results.
Are Daxor and Retractable Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.